Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Sentrimed Logo
Sentrimed CB Rank
780058
Heat Score
57
Sentrimed focuses on the development of cell-to-cell communication-based medicines that target validated drivers of cancer.
Founded
obfuscation
Private Mullica Hill, New Jersey, United States1-10 sentrimed.com
Biopharma
Biotechnology
Health Care
Overview

Sentrimed
Heat Score
57

Growth Score
pts
in past quarter
Heat Score 57
3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Sentrimed

CB Rank
780058
Sentrimed focuses on the development of cell-to-cell communication-based medicines that target validated drivers of cancer.
Founded
obfuscation
Private Mullica Hill, New Jersey, United States1-10 sentrimed.com
Biopharma
Biotechnology
Health Care

Details

Operating Status Active
Company Type For Profit
Phone Number 1 (856) 651-7140
Contact Email info@sentrimed.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

MASL
An orally administered inhibitor targeting podoplanin (PDPN) to block cancer cell motility, proliferation, and metastasis.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News

News and Press

News•Aug 7, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

587

IT Spend

$235.2KThis year, Sentrimed is projected to spend $235.2K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Inmate Education Logo
Inmate Education
78
Transportation Security Logo
Transportation Security
75
Building Security Logo
Building Security
69

Active Website Tech Count

20Sentrimed is actively using 20 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Viewport Meta, and  SSL by Default.

Total IP

4The intellectual property of Sentrimed includes 2 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Sentrimed has registered 2 trademarks with the most popular class being 'Chemical substances', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Sentrimed's headquarters? Sentrimed is located in Mullica Hill, New Jersey, United States.Who are Sentrimed's competitors? Alternatives and possible competitors to Sentrimed may include Eli Lilly, Sanofi, and  Pfizer.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(05b78c5 1)
|